Pieris Pharmaceuticals Inc (PIRS)
17.00
-0.30
(-1.73%)
USD |
NASDAQ |
Nov 04, 16:00
17.00
0.00 (0.00%)
After-Hours: 20:00
Pieris Pharmaceuticals Net Income (Annual): -24.54M for Dec. 31, 2023
Net Income (Annual) Chart
Historical Net Income (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | -24.54M |
| December 31, 2022 | -33.28M |
| December 31, 2021 | -45.74M |
| December 31, 2020 | -37.23M |
| December 31, 2019 | -25.47M |
| December 31, 2018 | -26.75M |
| December 31, 2017 | -17.65M |
| Date | Value |
|---|---|
| December 31, 2016 | -22.80M |
| December 31, 2015 | -14.06M |
| December 31, 2014 | -9.85M |
| June 30, 2014 | -0.0157M |
| December 31, 2013 | 0.0662M |
| June 30, 2013 | -0.0003M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Annual) Range, Past 5 Years
-45.74M
Minimum
2021
-24.54M
Maximum
2023
-33.25M
Average
-33.28M
Median
2022
Net Income (Annual) Benchmarks
| Ligand Pharmaceuticals Inc | 52.15M |
| NovaBay Pharmaceuticals Inc | -9.64M |
| Palatin Technologies Inc | -29.74M |
| iBio Inc | -24.91M |
| Theriva Biologics Inc | -18.35M |